Immunohistochemistry
At National Path Lab (NPL), we offer advanced Immunohistochemistry (IHC) testing with over 80 markers to provide precise and accurate diagnosis of various cancers and diseases. We are using cutting edge fully automated staining system for reliable results with quick turnaround time. The results are interpretated by highly skilled and experienced Pathologists ensuring accurate and meaningful diagnosis.
What is Immunohistochemistry (IHC)?
What is Immunohistochemistry (IHC)?
IHC is a specialized laboratory technique used to detect specific proteins in tissue samples. This helps in identifying the type of disease, especially in cancer diagnosis, prognosis, and treatment planning.
Our panel includes tests for critical disorders such as:
ER, PR, HER2, Ki-67 (Hormone receptor status for targeted therapy)
Lung Cancer: ALK, PD-L1 (Helps determine immunotherapy suitability)
Lymphomas & Leukemias: Early CD3, CD20, CD30, Ki-67 (Helps classify blood cancers)
Prostate Cancer: PSA, AMACR
Colon Cancer: MLH1, MSH2, MSH6, PMS2 (Identifies hereditary cancer risk)
Soft Tissue Tumors: Desmin, S100, Myogenin
Why is IHC Important in Cancer Diagnosis?
- Identifies the origin of cancer – Some tumors are difficult to classify under a microscope alone. IHC provides specific markers to determine where cancer started.
- Guides targeted therapy – Certain cancers respond to specific treatments. IHC helps oncologists choose the most effective treatment.
- Predicts prognosis – Helps in assessing how aggressive a tumor is and the likelihood of its spread.
